<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04848298</url>
  </required_header>
  <id_info>
    <org_study_id>IIBSP-MRE-2020-86</org_study_id>
    <nct_id>NCT04848298</nct_id>
  </id_info>
  <brief_title>Use of mHealth to Increase Physical Activity for Patients Recently Hospitalized With Acute Heart Failure</brief_title>
  <acronym>mRehab</acronym>
  <official_title>Use of mHealth to Increase Physical Activity for Patients Recently Hospitalized With Acute Heart Failure: a Randomized Clinical Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of this trial is to determine if a mobile application that promotes physical exercise&#xD;
      in the follow-up of patients recently hospitalized with acute heart failure can improve&#xD;
      exercise capacity after 6 months and physical activity levels compared to the standard&#xD;
      follow-up.&#xD;
&#xD;
      A randomized clinical trial will be conducted with 100 consecutive patients aged +18 years,&#xD;
      hospitalized for acute decompensated heart failure in a tertiary referral hospital who own a&#xD;
      mobile phone compatible with MyPlan and access to Wi-Fi or mobile data. At discharge,&#xD;
      patients will be randomly assigned in two groups; the intervention group will be followed&#xD;
      with a smartphone application to promote physical activity, whereas the control group will&#xD;
      take responsibility in their adherence to exercise recommendations. Main study variables will&#xD;
      be functional capacity after 6 months, which will be evaluated using the six minute walking&#xD;
      test, and physical activity levels, using the International Physical Activity Questionnaire&#xD;
      (IPAQ). The study will be analyzed using the intention-to-treat principle. The project has&#xD;
      been authorized by the local committee for ethics in clinical research.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">April 22, 2021</start_date>
  <completion_date type="Anticipated">March 31, 2023</completion_date>
  <primary_completion_date type="Anticipated">October 30, 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Supportive Care</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change in 6-minute walking distance (6MWD)</measure>
    <time_frame>6 months</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Participant reported physical activity levels, using the International Physical Activity Questionnaire (IPAQ)</measure>
    <time_frame>6 months</time_frame>
    <description>Results will be reported in categories (low activity levels, moderate activity levels or high activity levels) and as a continuous variable (MET minutes a week)</description>
  </secondary_outcome>
  <other_outcome>
    <measure>Muscle strength - measured using the Medical Research Council (MRC) Sum Score</measure>
    <time_frame>6 months</time_frame>
    <description>The total MRC sum score ranges from 0 (total paralysis) to 60 (normal strength).</description>
  </other_outcome>
  <other_outcome>
    <measure>Upper limb strenght - measured by hand-held dynamometry</measure>
    <time_frame>6 months</time_frame>
    <description>This instrument is scored using force production in kilograms (0-90)</description>
  </other_outcome>
  <other_outcome>
    <measure>Rectus femoris muscle diameter</measure>
    <time_frame>6 months</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>Physical function measured by the Short Physical Performance Battery score</measure>
    <time_frame>6 months</time_frame>
    <description>Each task is scored from 0 to 4, with 4 being the best, and a total battery score of 12 points</description>
  </other_outcome>
  <other_outcome>
    <measure>Participant reported quality of life - measured using the Minnesota living with heart failure questionnaire (MLHFQ)</measure>
    <time_frame>6 months</time_frame>
    <description>Each item is scored in a 6-point Likert Scale (0 to 5), thus the total score could range from 0 to 105, with higher scores indicating more significant impairment in health-related quality of life</description>
  </other_outcome>
  <other_outcome>
    <measure>NT-proBNP levels</measure>
    <time_frame>6 months</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>Readmission rate for Heart Failure</measure>
    <time_frame>6 months</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>Participant reported time dedicated to exercise recommendations</measure>
    <time_frame>6 months</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>Number of steps -measured using the built-in smartphone pedometer</measure>
    <time_frame>6 months</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>User satisfaction with the mHealth application (only experimental arm), measured by a customer satisfaction survey specifically designed for the trial</measure>
    <time_frame>6 months</time_frame>
  </other_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Heart Failure</condition>
  <arm_group>
    <arm_group_label>Mobile Health Arm</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Control Arm</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>The Control Arm will receive standard of care including tailored prescription of physical activity</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>mHealth Intervention</intervention_name>
    <description>The Mobile Health Arm will receive standard of care including tailored prescription of physical activity as well as the mobile health intervention, which will have the following features:&#xD;
Goal setting for frequency and duration of exercise sessions&#xD;
Graphic feedback and reinforcement with educational and motivational messages tailored to user's exercise adherence.&#xD;
Problem-solving support&#xD;
Library with educational tips and information regarding physical exercise.</description>
    <arm_group_label>Mobile Health Arm</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Aged +18 years&#xD;
&#xD;
          -  Hospitalized for acute decompensated heart failure in a tertiary referral hospital&#xD;
&#xD;
          -  Owning a mobile phone compatible with MyPlan and access to Wi-Fi or mobile data&#xD;
             (either the patient or the caregiver)&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  NYHA IV patients&#xD;
&#xD;
          -  Currently listed for heart transplant&#xD;
&#xD;
          -  Left ventricular assist device recipient&#xD;
&#xD;
          -  Ventricular arrhythmia within prior 6 months&#xD;
&#xD;
          -  Uncontrolled arterial hypertension or resting heart rate &gt;100 bpm&#xD;
&#xD;
          -  Acute myocarditis or pericarditis&#xD;
&#xD;
          -  Severe aortic stenosis&#xD;
&#xD;
          -  Hypertrophic obstructive cardiomyopathy&#xD;
&#xD;
          -  Advanced AV block&#xD;
&#xD;
          -  Muscle-skeletal or neurologic disease preventing to perform study procedures&#xD;
&#xD;
          -  ACS within prior month&#xD;
&#xD;
          -  Severe lung disease&#xD;
&#xD;
          -  Moderate or severe cognitive impairment&#xD;
&#xD;
          -  Unable/unwilling to consent&#xD;
&#xD;
          -  Projected life expectancy &lt;6 months&#xD;
&#xD;
          -  Clinical judgment concerning other safety issues&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Sonia Mirabet, Ph. D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Hospital de la Santa Creu i Sant Pau</name>
      <address>
        <city>Barcelona</city>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sonia Mirabet, Ph. D.</last_name>
      <phone>935565958</phone>
      <email>cardiologia@santpau.cat</email>
    </contact>
  </location>
  <location_countries>
    <country>Spain</country>
  </location_countries>
  <verification_date>April 2021</verification_date>
  <study_first_submitted>April 8, 2021</study_first_submitted>
  <study_first_submitted_qc>April 13, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">April 19, 2021</study_first_posted>
  <last_update_submitted>April 22, 2021</last_update_submitted>
  <last_update_submitted_qc>April 22, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">April 23, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Heart Failure</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

